Form 4: Pharvaris CMO Peng Lu Reports Stock Withholding

Chief Medical Officer Peng Lu reported the withholding of 109 shares of Pharvaris N.V. common stock to satisfy tax obligations.

Summary

• Peng Lu, Chief Medical Officer of Pharvaris N.V., executed a transaction involving the withholding of 109 shares of common stock.
• The transaction occurred on June 11, 2026, at a price of $31.51 per share.
• The withholding was conducted to satisfy tax obligations related to the vesting of restricted stock units.
• Following this transaction, Peng Lu maintains beneficial ownership of 65,748 shares of Pharvaris common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a routine administrative transaction required for tax compliance.

Positives

• The transaction is a routine administrative action related to tax obligations upon the vesting of equity compensation, rather than a discretionary sale.

Negatives

• None identified; this is a standard tax-related withholding event.

Risks

• None identified; this filing pertains to routine executive compensation tax compliance.

Future Outlook

No forward-looking guidance or strategic outlook provided in this filing.

Industry Context

StockSavvy.ai notes that this filing is a standard regulatory disclosure for executive equity compensation and does not reflect a change in management's sentiment toward the company's long-term prospects.

Comparison to Industry Standards

• The transaction follows standard industry practices for handling tax withholding obligations associated with the vesting of equity awards for corporate executives.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a routine tax-related withholding.

Key Dates

Keywords

Pharvaris, PHVS, Form 4, Insider Trading, Equity Compensation, Chief Medical Officer